abdominal and pelvic sarcoma
Conditions
Interventions
4DCT imaging
Sponsors
National Institute of Quantum Science and Technology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients scheduled to undergo carbon ion radiotherapy for abdominopelvic tumors within the registration period (from the date of research approval until March 31, 2025). 2) Persons who wish to participate in the research based on their own will and who are judged by the researcher's doctor to be able to understand the informed consent document. 3) If the research subject is a minor, consent can be obtained from a representative.
Exclusion criteria
Exclusion criteria: 1) Those whose heavy ion radiotherapy was discontinued for some reason after consent was obtained. 2) Persons in whom an unexpected abnormality was found in a test conducted after consent was obtained. 3) Persons who have difficulty performing the two types of CT scans due to cognitive impairment. 4) Persons with metal implants that affect treatment planning CT. 5) Other persons who are judged to be ineligible as research subjects by a doctor who is a researcher, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To calculate the dose distribution and LET distribution in the phase used for irradiation and evaluate the influence of respiratory movement on DVHs and LET distributions of tumors, and organs at risk. | — |
Countries
Japan
Contacts
Public ContactReiko Imai
National Institute of Quantum Science and Technology QST Hospital
Outcome results
None listed